Adding rivaroxaban to standard care can reduce the incidence of limb, heart, and brain events in patients with PAD who have undergone a recent peripheral revascularization, according to new data ...
In April, an ejection seat manufacturer officially notified the Naval Surface Warfare Center Indian Head Division (NSWC IHD) Cartridge Actuated Devices/Propellant Actuated Devices (CAD/PAD) Joint ...
During the month of May, the Cartridge and Propellant Actuated Device (CAD/PAD) Joint Program supported two workshops sponsored by NAVAIR's Program Management Air (PMA) 201 at the College of Southern ...
Patients who have both coronary and peripheral artery disease experience consistent reductions in ischemic complications after coronary stent placement when treated with extended dual antiplatelet ...
"We have shown that a younger age at diagnosis of PAD (low ABI or calcified arteries) is associated with increased risk of cardiovascular events. This is powerful information for both primary care ...
We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio Janssen Pharmaceuticals announced that ...
US regulators have approved Bayer/Janssen’s Xarelto to cut the risk of major cardiovascular (CV) events in people with chronic coronary or peripheral artery disease (CAD/PAD). US regulators have ...
Please provide your email address to receive an email when new articles are posted on . Among patients with peripheral artery disease who underwent revascularization, those with concomitant clinical ...
“Diabetes and pre-diabetes are associated with increased risk of atherosclerotic cardiovascular disease (ASCVD), defined as coronary heart disease, cerebrovascular disease, or PAD,” notes Dr. Helena ...
The European Commission (EC) has approved a regimen of rivaroxaban (Xarelto, Bayer) 2.5 mg twice daily plus acetylsalicylic acid (ASA) 75 to 100 mg once daily for the prevention of atherothrombotic ...
When peripheral artery disease (PAD) is known to accompany coronary artery disease (CAD) in people with diabetes, their already elevated risk of peripheral ischemic events rises even further. But so ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback